Anti-PR3 and anti-MPO IgG ANCA in autistic children with chronic GI disease

Immunology and Immunogenetics Insights

Volumn 1, Issue 1, 2009, Pages 21-28

  Russo, A J ^a   Krigsman, A ^b   Jepson, B ^b   Wakefield, Andrew ^b  

^a MOUNT ST MARY S UNIVERSITY   (United States)

^b Thoughtful House Center for Children   (United States)

Author keywords

ANCA; Autism; GI disease

Indexed keywords

EID: 83455265456     PISSN: None     EISSN: 11786345     Source Type: Journal    
DOI: 10.4137/iii.s1040     Document Type: Article

References (30)

1. Van der Woude FJ, Lobatto S, Permin H, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1985;i:425-9. [PubMed].
2. Niles JL, McCluskey RT, Ahmad MF, Arnaout MA. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood. 1989;74:1888-93. [PubMed].
3. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiolical potential. Kidney Int. 1994;46:1-15. [PubMed].
4. Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med. 1988;318:1651-7. [PubMed].
5. Charles LA, Falk RJ, Jennette JC. Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. Clin Immunol Immunopathol. 1989;53:243-53. [PubMed].
6. Kallenberg CGM, Mulder AHL, Cohen Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in infl ammatory disorders. Am J Med. 1992;93:675-82. [PubMed].
7. Saxon A, Shanahan F, Landers CJ, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with infl ammatory bowel disease. J Allergy Clin Immunol. 1990;86:202-10. [PubMed].
8. Rump JA, Schölmerich J, Gross V, et al. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiol. 1990;181:406-13.
9. Duerr RH, Targan SR, Landers CJ, et al. Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterol. 1991;100:1385-91.
10. Mulder AHL, Horst G, Haagsma EB, et al. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatol. 1993;17:411-7.
11. Roozendaal C, Van Milligen de Wit AWM, Haagsma EB, et al. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features. Am J Med. 1998;105:393-9. [PubMed].
12. Lassoued S, Sixou L, Oksman F, et al. Antineutrophil cytoplasmic antibodies and antibodies to myeloperoxidase in rheumatoid arthritis. Arthritis Rheum. 1991;34:1069-70. [PubMed].
13. Mulder AHL, Horst G, Van Leeuwen MA, et al. Anti-neutrophil cytoplasmic antibodies in rheumatoid arthritis: characterization and clinical correlates. Arthritis Rheum. 1993;36:1054-60. [PubMed].
14. Schnabel A, Csernok E, Isenberg DA, et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus: prevalence, specificities, and clinical significance. Arthritis Rheum. 1995;38:633-7. [PubMed].
15. Spronk PE, Bootsma H, Horst G, et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol. 1996;35:625-31. [PubMed].
16. Freeman HJ. Infl ammatory bowel disease with cytoplasmic-staining antineutrophil cytoplasmic antibody and extensive colitis. Can J Gastroenterol. 1998;12:279-82. [PubMed].
17. Fiocchi C. Infl ammatory bowel disease: etiology and pathogenesis. Gastroenterol. 1998;115:182-205.
18. Folwaczny C, Noehl N, Tschop K, et al. Goblet cell autoantibodies in patients with infl ammatory bowel disease and their first-degree relatives. Gastroenterol. 1997;113:101-6.
19. Geng X, Biancone L, Dai HH, et al. Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. Gastroenterol. 1998;114:912-22.
20. Stevens TRJ, Harley SL, Groom, et al. Anti-endothelial cell antibodies in inflammatory bowel disease. Dig Dis Sci. 1993;38:426-32. [PubMed].
21. Klein R, Eisenburg J, Weber P, et al. Significance and specificity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatol. 1991;14:1147-52.
22. D'Eufemia, P, Celli, M, Finocchiaro R, et al. Abnormal intestinal permeability in children with autism. Acta Paediatrica. 1996;85: 1076-9.
23. Furlano RI, Anthony A, Day R et al. Lymphocytic colitis, with CD8 and T cell infiltration and epithelial damage, in children with autism. J Pediatr. 2001;138:366-372.
24. Erickson, C. A., Stigler, K. A. et al. Gastrointestinal factors in autistic disorder: a critical review. J Autism Dev Disord. 2005;35(6):713-27.
25. Wakefield AJ, Ashwood P, Limb K, Anthony A. The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol. 2005 Aug; 17(8):827-36.
26. Ashwood P, Wills S, Van de Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol. 2006;Jul; 80(1):1-15.
27. Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral D, Van de Water J. Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci. 2007 Jun;1107:79-91.
28. Cabanlit M, Wills S, Goines P, Ashwood P, Van de Water J. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci. 2007 Jun;1107:92-103.
29. Ashwood P, Anthony A, Torrente F, Wakefield AJ., Spontaneous mucosal lymphocyte cytokine profiles in children with regressive autism and gastrointestinal symptoms: Mucosal immune activation and reduced counter regulatory interleukin-10. Journal of Clinical Immunology. 2004:24:664-673.
30. Ashwood P, Wakefield AJ. Ileal and peripheral blood CD3+ cytokine profiles in children with regressive autism and gastrointestinal symptoms: Mucosal immune activation and reduced counter regulatory interleukin-10. Journal of Neuroimmunology. 2006;73:126-34.